ArticleProceedings of the National Academy of Sciences of the United States of America2025

PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy.

Andres Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.